Published in Int J Antimicrob Agents on January 01, 1992
Parenteral-oral switch in the management of paediatric pneumonia. Drugs (1994) 0.77
Cefetamet pivoxil vs cefaclor in the treatment of acute otitis media in children. Drugs (1994) 0.75
Comparative pharmacokinetics of the new oral cephalosporins. Drugs (1994) 0.75
Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs. Drugs (1994) 0.75
Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther (1981) 2.93
Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis (2010) 2.60
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.35
Cloning and characterization of a phosphopantetheinyl transferase from Streptomyces verticillus ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin. Chem Biol (2001) 2.25
Identification of a novel SNF2/SWI2 protein family member, SRCAP, which interacts with CREB-binding protein. J Biol Chem (1999) 1.97
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. Antimicrob Agents Chemother (1984) 1.70
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans. Antimicrob Agents Chemother (1988) 1.64
Single-dose pharmacokinetics of ceftriaxone in infants and young children. Antimicrob Agents Chemother (1982) 1.59
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life. Chemotherapy (1981) 1.59
Purification of nerve growth factor antibodies by affinity chromatography. J Neurochem (1976) 1.49
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos (1997) 1.43
Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects. Antimicrob Agents Chemother (1989) 1.41
Problems in regaining full extension of the knee after anterior cruciate ligament reconstruction: does arthrofibrosis exist? Knee Surg Sports Traumatol Arthrosc (1994) 1.41
Primary Cancer of the Lung. Cal West Med (1945) 1.38
Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther (1995) 1.28
Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. Eur J Clin Pharmacol (1982) 1.27
An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. J Neurochem (1977) 1.26
Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis (1988) 1.24
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit (1994) 1.24
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Effects of a three-year exercise program on motor function and cognitive processing speed in older women. Res Q Exerc Sport (1991) 1.19
Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans. J Pharm Sci (1982) 1.18
Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological study. Brain Res (1975) 1.17
Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol (1993) 1.15
Increased theophylline concentrations secondary to ciprofloxacin. Drug Intell Clin Pharm (1987) 1.13
Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy. Eur J Clin Pharmacol (1986) 1.12
Biological importance of retrograde axonal transport of nerve growth factor in adrenergic neurons. Brain Res (1975) 1.09
A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin). Proteins (1997) 1.07
Screening methods using sulfamethazine for determining acetylator phenotype. Clin Pharmacol Ther (1979) 1.06
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations. Eur J Clin Pharmacol (1983) 1.05
Role of gangliosides in the uptake and retrograde axonal transport of cholera and tetanus toxin as compared to nerve growth factor and wheat germ agglutinin. Brain Res (1977) 1.05
Retrograde axonal transport of nerve growth factor: specificity and biological importance. Brain Res (1975) 1.05
Age-associated changes in ceftriaxone pharmacokinetics. Clin Pharmacokinet (1986) 1.04
The first adult case with 4-hydroxybutyric aciduria. J Inherit Metab Dis (1990) 1.04
Vancomycin protein binding in patients with infections caused by Staphylococcus aureus. DICP (1991) 1.03
Effect of norfloxacin on theophylline pharmacokinetics at steady state. Antimicrob Agents Chemother (1988) 1.02
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am J Hematol (2001) 1.02
Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob Agents Chemother (1990) 1.01
Pharmacokinetics of carumonam in patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.01
New analogs of trimethoprim. Rev Infect Dis (1982) 0.97
Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Antimicrob Agents Chemother (1990) 0.97
One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci (1992) 0.97
Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers. Antimicrob Agents Chemother (1989) 0.96
Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man. Br J Clin Pharmacol (1992) 0.96
Clinical pharmacokinetics of oral cephalosporins. Antibiot Chemother (1971) (1995) 0.96
Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues. Biochemistry (1998) 0.95
The significance of retrograde axonal transport for the accumulation of systemically administered nerve growth factor (NGF) in the rat superior cervical ganglion. Brain Res (1976) 0.95
Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients. Antimicrob Agents Chemother (1990) 0.94
Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants. Antimicrob Agents Chemother (1996) 0.94
The biosynthetic gene cluster for the anticancer drug bleomycin from Streptomyces verticillus ATCC15003 as a model for hybrid peptide-polyketide natural product biosynthesis. J Ind Microbiol Biotechnol (2001) 0.93
Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557. Antimicrob Agents Chemother (2009) 0.92
Recent advances: the cytochrome P450 enzymes. Ann Pharmacother (1995) 0.92
Single-dose ceftriaxone kinetics in liver insufficiency. Clin Pharmacol Ther (1984) 0.91
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Bioavailability of syrup and tablet formulations of cefetamet pivoxil. Antimicrob Agents Chemother (1993) 0.90
Fluoroquinolone antibacterials enhance UVA-induced skin tumors. J Photochem Photobiol B (1997) 0.90
Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737. Antimicrob Agents Chemother (1997) 0.90
Endometrial cancer metastasis presenting as a grossly swollen toe. Int J Gynecol Cancer (2003) 0.90
Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacology (Berl) (1989) 0.90
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther (1995) 0.90
Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J Pediatr (1984) 0.89
Cefetamet pivoxil in paediatric patients suffering from lower respiratory tract infections. Pharmatherapeutica (1989) 0.89
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. Clin Neuropharmacol (1996) 0.89
Protein binding of ceftriaxone in extravascular fluids. J Pharm Sci (1988) 0.89
In vitro interactions between beta-lactam antibiotics and tobramycin. Clin Chem (1981) 0.89
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
Determination of midazolam and its alpha-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography. Ther Drug Monit (1993) 0.89
Aromatic acids derived from phenylalanine in the tissues of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1972) 0.89
Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Curr Med Res Opin (1989) 0.88
Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil. J Pharmacokinet Biopharm (1992) 0.88
Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review). Chemotherapy (1981) 0.88
Single-dose ceftriaxone kinetics in functionally anephric patients. Clin Pharmacol Ther (1983) 0.88
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase. J Pharmacol Exp Ther (2002) 0.88
Adrenal epinephrine and norepinephrine release to hypoglycemia measured by microdialysis in conscious rats. Am J Physiol (1997) 0.88
Effects of hydrocortisone on lymphocytes stimulated by phytohaemagglutinin and pokeweed mitogen. Vox Sang (1972) 0.87
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrob Agents Chemother (1991) 0.87
The intravitreal penetration of ceftriaxone in man following systemic administration. Invest Ophthalmol Vis Sci (1989) 0.87
Single-dose ceftriaxone kinetics in the newborn. Clin Pharmacol Ther (1985) 0.87
Transcranial direct current stimulation (tDCS) and robotic practice in chronic stroke: the dimension of timing. NeuroRehabilitation (2013) 0.87
Regional expression and androgen regulation of carbonic anhydrase IV and II in the adult rat epididymis. Biol Reprod (1999) 0.86
Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1973) 0.86
A radiological method for producing precise limb alignment. J Bone Joint Surg Br (1991) 0.86
Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model. Am J Med (1984) 0.86
Fleroxacin: a review of its chemistry, microbiology, toxicology, pharmacokinetics, clinical efficacy and safety. Int J Antimicrob Agents (1993) 0.85
Fraction unbound in interstitial fluid. J Pharm Sci (1983) 0.85
Successful bone marrow grafts in experimental aplastic anemia using antilymphocytic serum for conditioning. Rev Eur Etud Clin Biol (1971) 0.85
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol (1983) 0.84
Predicted tissue accumulation of netilmicin in patients. Antimicrob Agents Chemother (1981) 0.84
Triphosphopyridine nucleotide specific isocitrate dehydrogenase from Azotobacter vinelandii. Alkylation of a specific methionine residue and amino acid sequence of the peptide containing this residue. Biochemistry (1974) 0.84